98 related articles for article (PubMed ID: 32987529)
1. Multi-scale modeling identifies the role of p53-Gys2 negative feedback loop in cellular homeostasis.
Sun TZ; Mu D
Math Biosci Eng; 2020 Apr; 17(4):3260-3273. PubMed ID: 32987529
[TBL] [Abstract][Full Text] [Related]
2. A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.
Chen SL; Zhang CZ; Liu LL; Lu SX; Pan YH; Wang CH; He YF; Lin CS; Yang X; Xie D; Yun JP
Cancer Res; 2019 Feb; 79(3):534-545. PubMed ID: 30584071
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
[TBL] [Abstract][Full Text] [Related]
4. MDM2-p53 pathway in hepatocellular carcinoma.
Meng X; Franklin DA; Dong J; Zhang Y
Cancer Res; 2014 Dec; 74(24):7161-7. PubMed ID: 25477334
[TBL] [Abstract][Full Text] [Related]
5. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
6. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback.
Wagner J; Ma L; Rice JJ; Hu W; Levine AJ; Stolovitzky GA
Syst Biol (Stevenage); 2005 Sep; 152(3):109-18. PubMed ID: 16986275
[TBL] [Abstract][Full Text] [Related]
7. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
8. Oscillatory Dynamics of p53 Genetic Network Induced by Feedback Loops and Time Delays.
Wang C; Liu H; Zhou J
IEEE Trans Nanobioscience; 2019 Oct; 18(4):611-621. PubMed ID: 31226080
[TBL] [Abstract][Full Text] [Related]
9. On p53 revival using system oriented drug dosage design.
Haseeb M; Azam S; Bhatti AI; Azam R; Ullah M; Fazal S
J Theor Biol; 2017 Feb; 415():53-57. PubMed ID: 27979498
[TBL] [Abstract][Full Text] [Related]
10. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
11. Oscillations by the p53-Mdm2 feedback loop.
Lahav G
Adv Exp Med Biol; 2008; 641():28-38. PubMed ID: 18783169
[TBL] [Abstract][Full Text] [Related]
12. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
13. MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53.
Wang W; Cheng JW; Qin JJ; Hu B; Li X; Nijampatnam B; Velu SE; Fan J; Yang XR; Zhang R
Cancer Lett; 2019 Sep; 459():156-167. PubMed ID: 31181320
[TBL] [Abstract][Full Text] [Related]
14. A dynamical model on the network of p53-Mdm2 feedback loop regulated by p14/19ARF.
Liu H; Han YR; Zhan Y; Chen YF; Zhang YH; Yu H; Zhao TJ; Zhuo YZ
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():4235-8. PubMed ID: 18002937
[TBL] [Abstract][Full Text] [Related]
15. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
16. The regulation of MDM2 by multisite phosphorylation--opportunities for molecular-based intervention to target tumours?
Meek DW; Hupp TR
Semin Cancer Biol; 2010 Feb; 20(1):19-28. PubMed ID: 19897041
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
García-Cano J; Sánchez-Tena S; Sala-Gaston J; Figueras A; Viñals F; Bartrons R; Ventura F; Rosa JL
Mol Oncol; 2020 Jan; 14(1):69-86. PubMed ID: 31665549
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Behavior of p53 Driven by Delay and a Microrna-34a-Mediated Feedback Loop.
Gao C; Liu H; Yan F
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070036
[TBL] [Abstract][Full Text] [Related]
19. TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.
Maeda R; Tamashiro H; Takano K; Takahashi H; Suzuki H; Saito S; Kojima W; Adachi N; Ura K; Endo T; Tamura TA
J Biol Chem; 2017 Feb; 292(8):3201-3212. PubMed ID: 28082682
[TBL] [Abstract][Full Text] [Related]
20. Mdm2-mediated ubiquitylation: p53 and beyond.
Marine JC; Lozano G
Cell Death Differ; 2010 Jan; 17(1):93-102. PubMed ID: 19498444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]